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Abstract
Background: Diabetes and obesity have reached epidemic proportions in the U.S. with rates consistently higher
among Hispanics as compared to non-Hispanic whites. Among Hispanic women diagnosed with gestational diabetes
mellitus (GDM), 50% will go on to develop type 2 diabetes within 5 years of the index pregnancy. Although randomised
controlled trials among adults with impaired glucose tolerance have shown that diet and physical activity reduce the
risk of type 2 diabetes, such programs have not been tested in high-risk postpartum women. The overall goal of this
randomised controlled trial is to test the efficacy of a culturally and linguistically modified, individually-tailored lifestyle
intervention to reduce risk factors for type 2 diabetes and cardiovascular disease among postpartum Hispanic women
with a history of abnormal glucose tolerance during pregnancy.
Methods/Design: Hispanic pregnant women who screen positive for GDM will be recruited and randomly assigned to a
Lifestyle Intervention (n = 150) or a Health & Wellness (control) Intervention (n = 150). Multimodal contacts (i.e., in-person,
telephone, and mailed materials) will be used to deliver the intervention from late pregnancy (29 weeks gestation) to
12 months postpartum. Targets of the intervention are to achieve Institute of Medicine Guidelines for postpartum weight
loss; American Congress of Obstetrician and Gynecologist guidelines for physical activity; and American Diabetes
Association guidelines for diet. The intervention draws from Social Cognitive Theory and the Transtheoretical Model and
addresses the specific cultural and environmental challenges faced by low-income Hispanic women. Assessments will be
conducted at enrollment, and at 6-weeks, 6-months, and 12-months postpartum by trained bicultural and bilingual
personnel blinded to the intervention arm. Efficacy will be assessed via postpartum weight loss and biomarkers of insulin
resistance and cardiovascular risk. Changes in physical activity and diet will be measured via 7-day actigraph data and
three unannounced 24-hour dietary recalls at each assessment time period.
Discussion: Hispanic women are the fastest growing minority group in the U.S. and have the highest rates of sedentary
behavior and postpartum diabetes after a diagnosis of GDM. This randomised trial uses a high-reach, low-cost strategy
that can readily be translated into clinical practice in underserved and minority populations.
Trial registration: NCT01679210
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Postpartum, Pregnancy, Gestational diabetes mellitus, Transtheoretical model
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Background
Type 2 diabetes is a global epidemic affecting approxi-
mately 21 million people in the U.S. [1]. The age at onset
for type 2 diabetes has decreased [1], highlighting the im-
portance of identifying high-risk groups early, in order to
implement prevention efforts. One such high-risk group is
women who develop glucose intolerance during pregnancy.
Both gestational diabetes mellitus (GDM) and milder glu-
cose intolerance in pregnancy identify women who are at
high risk for type 2 diabetes [2,3]. Indeed, a recent meta-
analysis found that GDM confers a 7-fold risk for future
type 2 diabetes [4] and up to one third of women with type
2 diabetes have previously been diagnosed with GDM [5].
According to a recent systematic review, the highest
risk period for the development of type 2 diabetes is
within the first 5 years after a GDM pregnancy [2], with
50% of Hispanic women developing type 2 diabetes within
5 years [6]. This is consistent with recent findings showing
a rapid postpartum change in glucose tolerance [7]; by
12 months postpartum, 17.1% of those with recent GDM
and 10% of women with milder degrees of gestational glu-
cose intolerance had progressed to prediabetes or diabetes
[8]. In other words, pregnancy unveils a preexisting sus-
ceptibility for type 2 diabetes and offers the opportunity to
implement interventions to decrease such risk.
In spite of these observations, studies of diabetes pre-
vention among high-risk postpartum women with history
of GDM are sparse. In the Diabetes Prevention Program
(DPP) [9] women with a history of GDM, approximately a
decade after their pregnancy, were able to decrease their
diabetes risk with a weight reduction goal of 7% of their
baseline weight even though they lost less weight than the
overall DPP sample (1.60 ± 0.80 kg vs. 4.03 ± 0.40 kg at
3 years, p = 0.021) [10]. This weight loss was achieved
through behavioral goals of ≥150 min per week of physical
activity and a low-fat, low-calorie diet. However, this trial
involved an intensive intervention not easily administered
in a clinical setting and was conducted an average of
12 years after GDM diagnosis such that women with early
postpartum conversion to diabetes, and therefore at high-
est risk, were not eligible. Other limitations included inter-
vening lifestyle factors and subsequent pregnancies which
may have modified findings, reliance on self-reported
diagnosis of GDM, lack of laboratory measures on glucose
tolerance during pregnancy, as well as a small percentage
of Hispanic women.
Weight loss can be achieved in the immediate postpar-
tum period [11], with studies finding that both energy
intake restriction and physical activity are needed to re-
duce weight [12,13], compared to exercise alone [14].
Similarly, weight loss interventions among non-pregnant
adults [15-17] have shown that multifaceted interven-
tions compared with stand-alone dietary advice, exercise
modification, or behavioral strategies yield significant
improvements in health outcomes and weight loss. A recent
review calculated that lifestyle interventions for women
with a history of GDM have the potential to delay or pre-
vent one-sixth of type 2 diabetes cases in the female popu-
lation [18].
Hispanics are the largest minority group in the U.S.,
with the highest birth and immigration rates of any mi-
nority group [19]. It is estimated that by 2050, Hispanic
women will comprise 30.2% of the female population in
the United States [20]. Hispanics are the most physically
inactive ethnic group in the U.S. [21] and are dispropor-
tionately affected by overweight and obesity. At each BMI
level, Hispanics have a higher prevalence of diabetes than
non-Hispanic whites [22-24]. Furthermore, a significant
proportion of Hispanics lack awareness of diabetes risk
factors and prevention strategies [25]. Despite the high
rates of progression of GDM to type 2 diabetes, only one
in five Hispanic women receive recommended postpartum
diabetes screening, the lowest follow-up frequency for any
group [26]. Due to cultural factors, socioeconomic cir-
cumstances, differences in educational background, and
language barriers, Hispanics have had limited access to
clinical and public health interventions that promote
healthy lifestyles. Therefore, the overall objective of this
trial is to test the ability of a lifestyle intervention, informed
by formative behavioral research, to reduce risk factors for
type 2 diabetes and cardiovascular disease among postpar-
tum Hispanic women with a recent history of abnormal
glucose tolerance (AGT) during pregnancy.
Aims
Specific aims are to achieve the Institute of Medicine
(IOM) guidelines for postpartum weight loss and to im-
prove maternal metabolic status by achieving and main-
taining 1) postpartum weight reduction to prepregnancy
weight if prepregnancy BMI was in the normal range, or
to achieve a 5% reduction from prepregnancy weight if
prepregnancy BMI was overweight/obese [27]; 2) at least
150 min per week of moderate intensity physical activity
such as brisk walking, as recommended by ACOG for
the postpartum period [28]; and 3) reduction in postpar-
tum total energy intake via reduced consumption of popu-
lar energy-dense foods (e.g., fast food, high-fat snacks,
fried foods and sugar-sweetened beverages), reduced por-
tion size, appropriate modifications in ethnic recipes, and
higher fruit and vegetable intake, as recommended by the
ADA [29].
Methods
Estudio Parto (Project Aiming to Reduce Type twO dia-
betes) will be based at the ambulatory obstetrical practices
of Baystate Medical Center in Western Massachusetts.
Eligible pregnant Hispanic women who screen positive
for GDM will be recruited between 24-28 weeks gestation
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and randomly assigned to a Lifestyle Intervention (n = 150)
or a Health & Wellness (control) Intervention (n = 150).
Multimodal contacts (i.e., in-person, telephone counseling,
and mailed print-based materials) will be used to deliver
the intervention from late pregnancy (29 weeks gestation)
to 12 months postpartum, encompassing introductory, ac-
tive, and maintenance phases (Figure 1).
Eligibility criteria
Baystate Medical Center practices universal screening
for GDM, which consists of a random 50-g glucose load
and a plasma glucose determination 1 hour later. If the
plasma glucose value is ≥135 mg/dL, a diagnostic 100-g
3 hour oral glucose tolerance test (OGTT) is conducted.
Eligible participants will be pregnant Hispanic women
who screen positive for GDM (50-g glucose load ≥135 mg/
dL). We will exclude women with: 1) history of type 1 or
type 2 diabetes, heart disease, or chronic renal disease, 2)
contraindications to postpartum participation in the trial’s
intervention activities which include engagement in moder-
ate physical activity and consumption of a low-fat/high-
fiber diet (e.g., Crohn’s disease, ulcerative colitis), 3) inability
to read English or Spanish at a 6th grade level, or 4) <18
or >45 years of age.
Recruitment
The trial will capitalize on our expertise in culturally ap-
propriate strategies for recruiting pregnant Hispanic
women in practice-based settings [30]. Specifically, bilin-
gual (Spanish and English) and bicultural health educators
will recruit women at the time of routine GDM screening.
Women will be informed of the aims and procedures of
the project and will be asked to sign a written informed
consent form, as approved by the Institutional Review
Boards of the University of Massachusetts-Amherst and
Baystate Health. Upon enrollment, the baseline assessment
will be conducted which includes: 1) data collection of
behaviors during pregnancy via standardized question-
naires, 2) measures of physical activity via an ActiGraph
GT3X-plus activity monitor (Actigraph LLC, Pensacola,
FL) to be worn on the wrist for the next 7 days, 3) mea-
sures of dietary intake via three unannounced 24-hr dietary
recalls over the following two-week period, 4) laboratory
measures of biomarkers of insulin resistance and cardio-
vascular risk via a study-specific fasting blood sample.
Completion of each assessment and blood draw is followed
by a gift card.
Randomisation
Randomisation to the Lifestyle Intervention or to the
Health & Wellness (control) Intervention will occur
at ~29 weeks gestation, after completion of the baseline
assessment. Randomisation will be stratified based on the
results of the diagnostic 100-g OGTT using thresholds
defined by the American Diabetes Association (ADA)
[31] (≥ 95 mg/dL fasting and ≥ 180 mg/dL, ≥155 mg/dL
and ≥140 mg/dL at 1 hour, 2 hours and 3 hours, re-
spectively): 1) no glucose values meeting or exceeding
the ADA thresholds; or 2) one or more glucose values
meeting or exceeding the ADA thresholds.
Lifestyle intervention
The Lifestyle Intervention is an evidence-based approach
utilizing culturally and linguistically modified, motiv-
ationally targeted, individually-tailored intervention ma-
terials developed in our prior randomised controlled
trials among Hispanics [32-39]. The intervention draws
from Social Cognitive Theory [40] and the Transtheore-
tical Model [41] and takes into account findings by our
research group on the specific social, cultural, economic,
Eligible  
Hispanic 
women
Lifestyle Intervention
Health & Wellness Intervention (Control)
Covariates 
1. Blood 
2. PPAQ 
3. Activity Monitor 
4. Diet recalls  
5. Pregnancy 
Medical Record
Enrollment and 
Randomization 
24-28 wks 
gestation 
Intervention: Active Period Intervention: Maintenance Period 
6 wks 
postpartum 
6 mos 
postpartum 
12 mos 
postpartum 
Baseline 
1. Blood 
2. PPAQ 
3. Activity Monitor 
4. Diet recalls  
5. Other measures 
listed in Table 1
6 mo Follow-Up 
1. Blood 
2. PPAQ 
3. Activity Monitor 
4. Diet recalls  
5. Other measures 
listed in Table 1
12-mo Follow-Up 
1. Blood 
2. PPAQ 
3. Activity Monitor 
4. Diet recalls  
5. Other measures 
listed in Table 1
Figure 1 Trial design.
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and environmental resources as well as challenges faced
by women of Hispanic backgrounds [25,42,43].
The Introductory Phase (~29 weeks gestation - delivery)
(Figure 1) will start with a face-to-face session. The goal of
this phase is to optimize gestational weight gain for the
remaining pregnancy period and move women over the
continuum of pre-contemplation to contemplation and
preparation for the postpartum Active Intervention Phase.
Motivational interviewing principles will be used to iden-
tify and strengthen women’s motivations for change. Spe-
cifically, the session will target knowledge and attitudes
regarding gestational weight gain, postpartum weight loss,
and type 2 diabetes prevention. Gestational weight gain
guidelines will be reviewed and participants will be pro-
vided with a digital scale.
The session will additionally include administration of
diet and physical activity questionnaires that facilitate
tailoring the intervention. The Diet Tailoring Question-
naire is a two-part survey consisting of a checklist of
high-calorie and lower-calorie foods and beverages com-
monly consumed by the target population. Respondents
are asked to indicate the frequency that they consume
the various foods and rate their confidence (self-efficacy)
in their ability to decrease high calorie and increase low
calorie food consumption. The Exercise Tailoring Ques-
tionnaire consists of 3 measures: Stages of Change for
Physical Activity [44], Processes of Change for Physical
Activity [45], and Self-Efficacy for Physical Activity [44].
This session will be followed by a third trimester booster
telephone counseling session which will review progress
toward gestational weight gain management and reinforce
preparation for postpartum weight loss. Print-based inter-
vention materials, in Spanish or English depending upon
participant preference and written at a 6th grade reading
level, will be mailed.
The Active Phase (6 weeks postpartum – 6 months
postpartum) (Figure 1) will start with a face-to-face ses-
sion. The tailoring questionnaires will be repeated and
counseling will include the development of individualized
weight loss, physical activity, and dietary goals. This ses-
sion will be followed by weekly, biweekly, and monthly
mailed, print-based materials as well as telephone booster
calls to provide motivationally-based individualized feed-
back. Specifically, mailed materials are culturally modified,
individually-tailored and motivationally targeted based on
responses to monthly mailed tailoring questionnaires.
Booster telephone sessions facilitate: 1) review of progress
toward dietary, physical activity and weight loss goals,
2) problem-solving of challenges faced in achieving goals
(e.g., balancing caregiver/household responsibilities, cul-
tural norms of self-sacrifice, limited social support, part-
ner negotiation, and neighborhood safety), 3) discussion
of mailed tip sheets, and 4) assistance with setting
new goals.
The Maintenance Phase (6 – 12 months postpartum)
(Figure 1) will involve continued telephone sessions and
mailed materials on a monthly and then bimonthly
schedule.
Curriculum
At the outset of the Active Phase of the intervention, a
weight-loss goal based on prepregnancy BMI will be set
and participants will be encouraged to work toward this
goal by focusing on a reduction of 1-2 pounds per week.
The health educator will utilize a checklist of motivators
for wanting to lose weight, specific to new mothers, to
help women identify their own weight loss motivations
and to reinforce engagement. Participants will be en-
couraged to weigh themselves at home daily and to chart
their weight on a grid weekly.
Physical activity change will be targeted via individualized
week-by-week goals that focus on increasing the time spent
in moderate intensity activity, as well as steps taken per day.
Women will choose what form of safe activity they
enjoy the most or can most readily fit into their lifestyle,
from dancing to walking in a shopping mall to yard work.
The accumulation of short bouts (i.e., 10 min episodes) will
be encouraged. Pedometers and activity logs will be pro-
vided for women to monitor their activity. Based on re-
sponses to the tailoring questionnaires, individually-tailored
computer Expert-System Feedback Reports [37,39,46,47]
will draw particular messages from a library of approxi-
mately 296 messages regarding motivation, self-efficacy,
and cognitive and behavioral strategies for exercise adop-
tion. Stage-Matched Manuals will focus on the benefits of
exercise, building social support for new behavioral pat-
terns, and strategies for overcoming barriers to exercise
specific to low-income Hispanic women. Tip Sheets include
topics such as stretching and exercising with baby (e.g.,
walking while pushing a stroller).
Dietary change will be targeted by working toward an
ultimate goal of 1,500 calories per day (up to 2,000 for
breastfeeding women who lose more than 2 lbs/week
over a 2 week period). Dietary goals will be tailored to
the participant based on responses to the Diet Tailoring
Questionnaires, which take into consideration energy-
dense foods that the participant eats frequently and feels
confident that she is able to reduce or replace, and lower
calorie foods which the participant eats infrequently and
feels confident that she can increase. Participants will be
instructed in how to self-monitor dietary intake using
the food calorie guide and a tip sheet for measuring por-
tion sizes. Participants will be provided with measuring
cups and a dietary log.
Quality control procedures will ensure that stage of
change and social cognitive constructs are consistently
represented in all intervention materials.
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Health & wellness (control) intervention
To ensure retention and to control for contact time, the
Health & Wellness (control) arm will receive mailed health
materials and telephone booster calls on the same schedule
as the Lifestyle Intervention arm. Mailed materials focus on
non-exercise and non-dietary topics and include booklets
from ACOG and the American Academy of Pediatrics in
English or Spanish. These booklets represent high-quality,
standard, low-cost, self-help material currently available
to the public. In this way, we control for contact time,
while keeping the content of the two interventions dis-
tinct. Hispanic control-arm participants in our prior studies
reported that these materials were of interest and differen-
tial dropout did not occur between study arms [36,48].
Outcome variables
Postpartum weight loss will be measured as the difference
between weight at 6 or 12 months postpartum and weight
at delivery, and will be calculated as absolute weight change
according to prepregnancy BMI, percentage who retain a
specific amount of weight over prepregnancy weight, or
proportion whose BMI category changes from prepreg-
nancy BMI category as have others (Table 1) [12-14].
Fasting biomarkers will be collected at baseline, and at
6-weeks, 6-months, and 1-year postpartum (Table 1).
Postpartum biomarkers of insulin resistance will include
glucose, insulin, HbA1c, leptin, TNF-α, HOMA, Area-
Under-The-Glucose Curve (AUC), and adiponectin. Post-
partum biomarkers of cardiovascular risk factors will
include blood lipids, blood pressure, C-reactive protein
(CRP), fetuin-A, and albumin-to-creatinine ratio (ACR).
Postpartum diabetes screening will occur at each postpar-
tum assessment and will follow the guidelines of the 2007
5th International Workshop Conference on GDM recom-
mending a postpartum 75-g OGTT [49] using diagnostic
criteria defined by the American Diabetes Association [31].
Behavioral outcomes
Women will be provided with the ActiGraph GT3X-plus
activity monitor to be worn on the wrist for 7-days at
each of the assessment time periods (enrollment, 6-weeks,
6-months, and 12-months postpartum). Previous studies
have reported reasonable validity under laboratory condi-
tions among pregnant women [50], as well as under free-
living conditions [51-53]. In addition, at each assessment
time period, trained bilingual personnel blinded to the
assigned intervention arm will conduct three unannounced
24-hr dietary recalls over a two-week period and ad-
minister the Pregnancy Physical Activity Questionnaire
(PPAQ) [54]. The PPAQ is a semi-quantitative question-
naire which evaluates participation in household/care-
giving, occupational, sports/exercise, and transportation
activities.
Covariates
Clinical characteristics of the current pregnancy and
medical history will be abstracted from the pregnancy
medical record (Table 1). Weight is measured prospect-
ively at each prenatal visit and postpartum weight will
be measured during assessment visits by trained study
staff to the nearest 0.1 kg on accurately calibrated standard
clinical scales using a standardized protocol. Gestational
age will be based upon the best clinical estimate as re-
corded in the medical record. Adherence with gestational
weight gain guidelines will be calculated by comparing the
observed weight gain with the 2009 IOM Guidelines [27].
We will also collect gestational age at the time of GDM
screen; degree of abnormality on glucose tolerance testing
during pregnancy; treatment for glucose abnormality dur-
ing pregnancy (e.g., diet, oral hypoglycemic agents and/or
insulin); pregnancy complications; and birth outcomes.
Sociodemographic factors will be collected via self-report
at enrollment. Acculturation will be assessed via the Psy-
chological Acculturation Scale [55], language preference,
and generation in the U.S. Smoking will also be assessed
via the biomarker cotinine. Postpartum factors will be col-
lected via self-report at each postpartum assessment and
will include: The Pittsburgh Sleep Quality Index (PSQI)
[56], the Edinburgh Postpartum Depression Scale [57,58],
and the Infant Feeding Questionnaire [59].
Data analysis
Primary analyses will evaluate differences in the change
from 6 weeks postpartum to 12 months postpartum be-
tween the groups (an intent to treat analysis) in postpar-
tum weight loss (aim #1), biomarkers of insulin resistance
(aim #2), and biomarkers of cardiovascular disease risk
(aim #3). We will use mixed models with random subject
effects, including a common mean at baseline for the
treatment groups, a period effect, and an intervention by
period interaction [60]. The mixed model analysis will en-
able inclusion of time varying covariates such as breast-
feeding behaviors, depression, and sleep, which may vary
between baseline and follow-up for individuals. Equiva-
lence of treatment groups will be assessed by comparing
distributions of the potential confounders across groups.
In addition, we will investigate established risk factors for
type 2 diabetes as potential confounders or effect modi-
fiers. Important potential effect modifiers include prepreg-
nancy BMI, and breastfeeding behaviors. Mixed model
analyses will also be used to account for the repeated mea-
sures of exercise and diet and will be used to evaluate
adoption and maintenance of behavior change (aim #4) in
the Lifestyle Intervention group.
Power and sample size
The study is powered to detect mean differences in
change in outcome variables from baseline in the Lifestyle
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Intervention as compared to the Health and Wellness
(control) Intervention that are equivalent to 0.35 to 0.40
standard deviations, or a “small-medium” effect size [61],
at 80% power at a 0.05 level of significance. A total of 256
women are required (128 participants per study arm).
With an expected attrition rate of 15%, 300 eligible
women will be recruited.
Discussion
This trial is innovative in testing a prenatal and postpar-
tum lifestyle intervention designed to reduce risk factors
for type 2 diabetes and cardiovascular disease among
high-risk Hispanic women. Changes in lifestyle risk factors
(e.g., postpartum weight loss through reduction in energy
intake and increased physical activity) among women who
Table 1 Variables collected at assessment time points
Pregnancy Postpartum
3rd trimester 6 wks 6 mos 12 mos
Aim #1: Postpartum weight loss X X X X
Aim #2: Postpartum biomarkers of insulin resistance
Glucose X X X X
Insulin X X X X
HbA1c X X X X
Adiponectin X X X X
Leptin X X X X
TNF-α X X X X
HOMA X X X X
Area-Under-The-Glucose Curve (AUC) X X X X
Aim #3: Other postpartum biomarkers of cardiovascular risk
Total cholesterol X X X X
Triglycerides X X X X
HDL-Cholesterol X X X X
LDL-Cholesterol X X X X
Systolic blood pressure X X X X
Diastolic blood pressure X X X X
CRP X X X X
Fetuin-A X X X X
Albumin-to-creatinine ratio (ACR), X
Aim #4: Behavioral outcomes
Physical activity (actigraph, PPAQ) X X X X
Dietary intake (24-hr recalls) X X X X
Censoring variables
Postpartumpregnancy test (urine) X X X
75 g OGTT (postpartum) X X X
Eligibility variables
100 g OGTT (prenatal) X
Covariates
Clinical characteristics of the current pregnancy X
Gestational weight gain X
Medical history X
Sociodemographic factors X
Smoking (Cotinine) and substance use X X X X
Postpartum factors (e.g., sleep, depression, breastfeeding) X X X
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experienced abnormal glucose tolerance in pregnancy may
reduce risk factors for type 2 diabetes and cardiovascular
disease. Guidelines for the management of the elevated risk
of diabetes among women with glucose abnormalities dur-
ing pregnancy have lagged behind its recognition [62].
Women receive closer medical attention during the pre-
natal and postpartum periods than at other times in their
adult lives, and are often highly motivated to improve their
health to benefit themselves and their children. This post-
partum lifestyle intervention capitalizes upon this teachable
moment, and extends prenatal randomized trials conducted
by our research team and others which utilized exercise
and/or diet to reduce the risk of excessive gestational
weight gain and gestational diabetes mellitus [36,63].
The low-income Hispanic population targeted by this
study will include Spanish speakers (~25%), a population
who have, overall, been excluded from research studies
[64] or are underrepresented in research even when re-
cruitment goals include Hispanics [65] despite the greater
health challenges they face. The trial includes novel mate-
rials developed specifically for this group, thus increasing
its innovation.
Investigation of which types of programs benefit post-
partum women and identification of women at particu-
larly high-risk are needed to increase the effectiveness of
any prevention efforts. The public health impact of such
lifestyle modifications is likely to be greatest in ethnic
groups, such as Hispanics, with consistently high rates of
obesity, diabetes, and the highest rates of sedentary behav-
ior. This randomised controlled trial uses a high-reach,
low-cost strategy, which can readily be translated into
clinical practice in underserved and minority populations.
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